Efficacy and safety of acarbose plus metformin fixed-dose combination versus acarbose monotherapy for type 2 diabetes: a randomised, double-blind, parallel-group study

被引：0
|
作者：
Wang, J. -S. [1 ]
Huang, C. -N. [2 ]
Hung, Y. -J. [3 ]
Kwok, C. -F. [4 ]
Sun, J. -H. [5 ]
Pei, D. [6 ]
Yang, C. -Y. [7 ]
Chen, C. -C. [8 ]
Lin, C. -L. [9 ]
Sheu, W. -H. [1 ]
机构：
[1] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan
[3] Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan
[5] Linkou & Taipei Chang Gung Mem Hosp, Dept Internal Med, Taipei, Taiwan
[6] Cardinal Tien Hosp, Dept Internal Med, Taipei, Taiwan
[7] Chi Mei Med Ctr, Div Endocrinol & Metab, Tainan, Taiwan
[8] China Med Univ Hosp, Div Endocrinol & Metab, Taichung, Taiwan
[9] Cathay Gen Hosp, Dept Internal Med, Taipei, Taiwan
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
970
引用
收藏
页码：S389 / S389
页数：1
相关论文
共 50 条
  • [1] Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes
    Wang, Jun-Sing
    Huang, Chien-Ning
    Hung, Yi-Jen
    Kwok, Ching-Fai
    Sun, Jui-Hung
    Pei, Dee
    Yang, Chwen-Yi
    Chen, Ching-Chu
    Lin, Ching-Ling
    Sheu, Wayne Huey-Herng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 102 (01) : 16 - 24
  • [2] Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes
    Joshi, Shashank R.
    Ramachandran, Ambady
    Chadha, Manoj
    Chatterjee, Sudip
    Rathod, Rahul
    Kalra, Sanjay
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1611 - 1620
  • [3] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
    Du, J.
    Liang, L.
    Fang, H.
    Xu, F.
    Li, W.
    Shen, L.
    Mu, Y.
    DIABETOLOGIA, 2016, 59 : S372 - S372
  • [4] Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study
    Bailey, CJ
    Bagdonas, A
    Rubes, J
    McMorn, SO
    Donaldson, J
    Biswas, N
    Stewart, MW
    CLINICAL THERAPEUTICS, 2005, 27 (10) : 1548 - 1561
  • [5] A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
    Aditi Jain
    Abhay Vispute
    Amol Dange
    Arindam Naskar
    Asish Mondal
    B. Vivekanand
    Balram Sharma
    Deepak Varade
    Dhaiwat Shukla
    Girish Bhatia
    Harshal Chaudhari
    K. Ram Babu
    Onkar Gavali
    Sanket Sorate
    Shaishav Bhanushali
    Vaibhav Kothari
    Vipul Khandelwal
    Akhilesh Sharma
    Roshan Pawar
    Mayur Mayabhate
    Vinayaka Shahavi
    Aashishsingh Rajput
    Mukesh Jaiswal
    Diabetes Therapy, 2024, 15 : 215 - 227
  • [6] A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
    Jain, Aditi
    Vispute, Abhay
    Dange, Amol
    Naskar, Arindam
    Mondal, Asish
    Vivekanand, B.
    Sharma, Balram
    Varade, Deepak
    Shukla, Dhaiwat
    Bhatia, Girish
    Chaudhari, Harshal
    Ram Babu, K.
    Gavali, Onkar
    Sorate, Sanket
    Bhanushali, Shaishav
    Kothari, Vaibhav
    Khandelwal, Vipul
    Sharma, Akhilesh
    Pawar, Roshan
    Mayabhate, Mayur
    Shahavi, Vinayaka
    Rajput, Aashishsingh
    Jaiswal, Mukesh
    DIABETES THERAPY, 2024, 15 (01) : 61 - 76
  • [7] Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study
    Kim, Sang Soo
    Kim, In Joo
    Lee, Kwang Jae
    Park, Jeong Hyun
    Kim, Young Il
    Lee, Young Sil
    Chung, Sung Chang
    Lee, Sang Jin
    JOURNAL OF DIABETES, 2017, 9 (04) : 412 - 422
  • [8] Efficacy of Glimepiride/Metformin Fixed-Dose Combination Versus Metformin Uptration in Type 2 Diabetic Patients Inadequately Controlled on Metformin Monotherapy, a Randomized, Multicenter, Parallel-Group, Open Study in Korea
    Kim, Hye-Soon
    Kim, Doo Man
    Cha, Bong Soo
    Park, Tae Sun
    Kim, Kyoung-Ah
    Kim, Dong-Lim
    Chung, Choon Hee
    Park, Jeong Hyun
    Jang, Hak Chul
    Choi, Dong-Seop
    DIABETES, 2011, 60 : A605 - A605
  • [9] Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study
    Kadowaki, Takashi
    Haneda, Masakazu
    Inagaki, Nobuya
    Terauchi, Yasuo
    Taniguchi, Atsushi
    Koiwai, Kazuki
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    ADVANCES IN THERAPY, 2015, 32 (04) : 306 - 318
  • [10] Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study
    Takashi Kadowaki
    Masakazu Haneda
    Nobuya Inagaki
    Yasuo Terauchi
    Atsushi Taniguchi
    Kazuki Koiwai
    Henning Rattunde
    Hans J. Woerle
    Uli C. Broedl
    Advances in Therapy, 2015, 32 : 306 - 318
12345